Dr. Sibgha Noureen is a Lecturer in the Department of Pharmacy at Qarshi University, Lahore, and a PhD Scholar in Pharmaceutical Chemistry at Government College University Faisalabad. With more than 7 years of academic and professional experience, her teaching expertise encompasses Medicinal Chemistry, Organic Chemistry, Pharmaceutical Analysis, Biochemistry, and Industrial Pharmacy. She has also undertaken professional development in Artificial Intelligence (AI) and advanced teaching methodologies, strengthening her capabilities in technology-enhanced education and contemporary academic practices.
Her research interests include drug discovery and design, gestational diabetes mellitus, biochemical analysis, antibiotic resistance, medication use during pregnancy, and health-related quality-of-life assessment. She has contributed to publications in internationally recognized peer-reviewed journals and has served as a peer reviewer for multiple scientific journals, including PLOS ONE, reviewing research manuscripts for scholarly publication. Her profile combines pharmaceutical education, research, academic writing, peer review, statistical analysis, and practical pharmacy experience.
| Education | ||
| PhD Pharmaceutical Chemistry Government College University Faisalabad (Ongoing)
Government College University, Faisalabad 2024–Present |
||
| M.Phil Pharmaceutical Chemistry Government College University Faisalabad
Government College University, Faisalabad 2020–2022 |
||
| Doctor of Pharmacy (PharmD) Government College University Faisalabad
Government College University, Faisalabad 2015–2020 |
||
| Experience | ||
| Designation / Organization | From | To |
| Lecturer, Qarshi University, Lahore | 2025 | Present |
| Lecturer, University of Chenab, Gujrat | 2023 | 2025 |
| Retail Pharmacist | 2020 | 2023 |
| Field of Interests | ||
| [1] | Drug discovery and design. | |
| [2] | Biochemical analysis of blood glucose, lipid profile, and Hb. | |
| [3] | GDM (Gestational Diabetes Mellitus). | |
| [4] | Lipid-profile alterations in pregnant females. | |
| [5] | Hb concentration variation in pregnant females. | |
| [6] | Antibiotic resistance. | |
| [7] | Self or prescription-only drugs in pregnant females. | |
| [8] | Immunity boosters in the era of COVID. | |
| [9] | EQ-5D-5L usage in the measurement of health-related quality of life. | |